1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. Y-MABS THERAPEUTICS INC
Y-Mabs Therapeutics Inc XNAS: YMAB

Y-Mabs Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

Read More
8.61 0.02 (0.23%)
46.52% Fall from 52W High
760.7K
XNAS Volume

XNAS 15 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
15.2 / 100
Momentum Score
Technically Moderately Bullish
62.9 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
9
1Yr Price target downside is 0%
5 analysts

15

S

5

W

1

O

3

T

SWOT Analysis

YMabs Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..